Nearly 40% of top Bitcoin treasury companies trade below NAV, with Strategy at 17% discount, raising consolidation and M&A ...

In 2025, Middle Eastern national oil companies anchored the global energy system by sustaining hydrocarbon primacy, expanding ...

Rocket Pharmaceuticals is a Buy, with strong catalysts, undervalued programs, and significant upside. Click here to read my analysis of RCKT stock.

Maybank Securities and Tickers Financial are both initiating “buy” calls on recently listed co-living operator Coliwoo ...

Berkshire Hathaway stock underperformed the broader market in 2025, but there’s ample reasons to believe BRK.B shares will ...

INTERVIEW: After a career of playing dashing gents, the Irish actor has transformed himself to play the late boxing trainer ...

Structural alpha investing explained. How corporate structure, spinoffs, capital allocation, and governance create hidden ...

Invitation Homes (INVH) upgraded to Strong Buy: discounted vs. NAV, 4.4% dividend yield, and resilient SFR fundamentals ...

Young Pennsylvanians believe the commonwealth’s institutions are slow to respond and are detached from daily realities, ...

Chief Human Resources Officers (CHRO) need to simplify, rationalize and re-build strategies in 2026 if they are to ...

Bybit Private Wealth Management reported its 2025 performance this week, showing that its highest-returning fund generated a ...

EUZ shares have declined 28% over the past six months, despite no structural business deterioration. The recent underperformance appears like a valuation dislocation, not reflecting EUZ's unique posit ...